Goldman Sachs’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-232,815
| Closed | -$32.6M | – | 4332 |
|
|
2018
Q4 | $32.6M | Buy |
232,815
+26,747
| +13% | +$3.75M | 0.01% | 1226 |
|
|
2018
Q3 | $35.2M | Sell |
206,068
-31,150
| -13% | -$5.32M | 0.01% | 1300 |
|
|
2018
Q2 | $41.2M | Buy |
237,218
+66,064
| +39% | +$11.5M | 0.01% | 1205 |
|
|
2018
Q1 | $19.7M | Buy |
171,154
+65,133
| +61% | +$7.51M | 0.01% | 1586 |
|
|
2017
Q4 | $8.93M | Sell |
106,021
-12,190
| -10% | -$1.03M | ﹤0.01% | 1969 |
|
|
2017
Q3 | $10.9M | Buy |
118,211
+28,983
| +32% | +$2.67M | ﹤0.01% | 1930 |
|
|
2017
Q2 | $7.16M | Buy |
89,228
+45,050
| +102% | +$3.61M | ﹤0.01% | 2092 |
|
|
2017
Q1 | $1.86M | Buy |
44,178
+2,045
| +5% | +$86.1K | ﹤0.01% | 2783 |
|
|
2016
Q4 | $1.35M | Buy |
+42,133
| New | +$1.35M | ﹤0.01% | 2926 |
|
|
2015
Q2 | – | Sell |
-30,547
| Closed | -$380K | – | 4817 |
|
|
2015
Q1 | $380K | Buy |
30,547
+1,440
| +5% | +$17.9K | ﹤0.01% | 3489 |
|
|
2014
Q4 | $342K | Sell |
29,107
-10,933
| -27% | -$128K | ﹤0.01% | 3606 |
|
|
2014
Q3 | $526K | Buy |
+40,040
| New | +$526K | ﹤0.01% | 3296 |
|